Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy (Q80166839)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Murray Epstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Nephrology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

310-311

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json

Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0192

7 January 2021

Aldosterone receptor blockade and the role of eplerenone: evolving perspectives

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0192

7 January 2021

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0192

7 January 2021

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0192

7 January 2021

Eplerenone: a new aldosterone receptor antagonist--are the FDAs restrictions appropriate?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0192

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16932450%20AND%20SRC:MED&resulttype=core&format=json